#Enzyme Immunoassay (EIA) Reagents and Devices Market trends
Explore tagged Tumblr posts
Visit Tumblr Blog
Explore Tumblr blogs with no restrictions, modern design and the best experience.
Last Seen Tumblr Blogs
Fun Fact
After the announcement of the deal with Yahoo!, there were 170K signatures of unhappy Tumblr users petitioning to prevent the sale in 2013.
Text
#Enzyme Immunoassay (EIA) Reagents and Devices Market share#Enzyme Immunoassay (EIA) Reagents and Devices Market size#Enzyme Immunoassay (EIA) Reagents and Devices Market trends
0 notes
Text
Blood Screening Market 2023- Business Planning Research and Resources, Revenue, and Forecasts 2030
Blood Screening Market Size & Trends
The global blood screening market size was valued at USD 2.76 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 11.7% from 2023 to 2030.
Blood screening is a process in which donated blood is screened for infectious diseases such as HBV, HCV, HIV1, and HIV2. The high growth of this market is attributed to rising blood donations, an increase in the incidence of infectious diseases, and government initiatives. According to World Health Organization (WHO), 118.54 million blood donations are collected yearly. In the U.S., 6.8 million individuals donate blood annually, and 13.6 million units of red blood cells and whole blood are collected annually.
Gather more insights about the market drivers, restrains and growth of the Blood Screening Market
The market is primarily driven by the rise in the rate of disorders such as HIV, diphtheria, measles and chronic diseases such as hemophilia, cancer, and other blood-related disorders. Blood-based diagnostics are used to diagnose a wide range of diseases, including infectious diseases, cancer, and cardiovascular diseases. Serology tests detect the presence of antibodies to a specific disease-causing organism. These tests diagnose various infectious diseases, including HIV, hepatitis B, and syphilis. Molecular tests detect the presence of DNA or RNA from a specific disease-causing organism. These tests are more sensitive than serology tests and can be used to diagnose diseases at an earlier stage. Biochemical tests measure the levels of certain substances in the blood. These tests can diagnose a wide range of diseases, including diabetes, kidney disease, and liver disease.
The COVID-19 pandemic had a significant impact on the market. Although respiratory droplets are the primary means of COVID-19 virus transmission, research has shown that viral RNA may be discovered in blood samples, supporting blood screening for COVID-19 identification, hence driving the market significantly.
Blood Screening Market Segmentation
Grand View Research has segmented the global blood screening market based on technology, product, and region:
Technology Outlook (Revenue, USD Million, 2018 - 2030)
Nucleic Acid Amplification Test (NAT)
ELISA
Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
Next Generation Sequencing
Western Blotting
Product Outlook (Revenue, USD Million, 2018 - 2030)
Reagent
Instrument
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
US
Canada
Europe
UK
Germany
France
Italy
Spain
Sweden
Norway
Denmark
Asia Pacific
Japan
China
India
Australia
Thailand
South Korea
Latin America
Brazil
Mexico
Argentina
Middle East and Africa
Saudi Arabia
South Africa
UAE
Kuwait
Browse through Grand View Research's Medical Devices Industry Research Reports.
The global embolic protection devices market size was valued at USD 612.9 million in 2023 and is projected to grow at a CAGR of 8.7% from 2024 to 2030.
The global covered stent market size was estimated at USD 1.13 billion in 2023 and is projected to grow at a CAGR of 4.1% from 2024 to 2030.
Key Companies & Market Share Insights
Product launches, approvals, strategic acquisitions, and innovations are just a few of the important business strategies used by market participants to maintain and grow their global reach.
For instance, in March 2023, Abbott received U.S Food and Drug Administration (FDA) clearance for a laboratory traumatic brain injury blood test, the first commercially available lab-based test for the assessment of mild traumatic brain injuries (TBIs), commonly referred to as concussions, which will be made widely available to hospitals across the U.S. This test, which is powered by Abbott’s Alinity i laboratory tool, will enable clinicians to evaluate individuals with mild traumatic brain injuries in a timely manner.
Furthermore, in May 2023, Siemens Healthcare introduced Atellica HEMA 570 and 580 next-generation hematology analyzers, which have user-friendly interfaces and can be connected to multiple analyzers to remove workflow barriers and provide high throughput time.
Key Blood Screening Companies:
Abbott
Danaher Corporation (Beckman Coulter)
Becton Dickinson and Company
Bio-Rad Laboratories, Inc.
Hoffman-La Roche Ltd.
Grifols, S.A.
Ortho-Clinical Diagnostics, Inc.
Siemens Healthcare GmbH
Thermo Fisher Scientific, Inc.
SOFINA s.a (Biomerieux)
Order a free sample PDF of the Blood Screening Market Intelligence Study, published by Grand View Research.
0 notes
Text
Global Enzyme Immunoassay (EIA) Reagents and Devices Market Growth Statistics to Make Multi-Billion Dollar Market during 2021-2028
Global Enzyme Immunoassay (EIA) Reagents and Devices Market Synopsis:
The top-notch Enzyme Immunoassay (EIA) Reagents and Devices Market research report has been structured by skilful and experienced team players who work hard to accomplish an absolute growth and success in the business. The Marketing report acts upon Market study and analysis to provide Market data by considering new product development from beginning to launch. The key research methodology employed throughout this report by DBMR research team is data triangulation which entails data mining, analysis of the impact of data variables on the Market, and primary validation. Adopting Enzyme Immunoassay (EIA) Reagents and Devices Market report is always beneficial for any company, whether it is small scale or large scale, for Marketing its products or services.
SWOT analysis has been performed while creating Enzyme Immunoassay (EIA) Reagents and Devices Market document along with many other standard steps of researching, analysing and collecting data. The report is formulated by considering several steps which can be summarised as follows. 1. Craft a title page 2. Fix a table of contents 3. Edit the report in the executive summary 4. Inscribe an introduction 5. Write the qualitative research segment of the body 6. Note down the survey research section of the body 7. Go over the types of data used in drawing conclusions 8. Allocate findings based on research 9. State conclusions and call the reader to action.
Get Sample Report + All Related Graphs & Charts @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-enzyme-immunoassay-eia-reagents-and-devices-market .
The Global Enzyme Immunoassay (EIA) Reagents and Devices Market will exhibit a CAGR of around 3.63% for the forecast period of 2021-2028.
According to market research study, Enzyme immunoassay (EIA) reagents and devices are used to detect the presence or concentration of an antigen with its application to epidemiological diseases detection. It includes different types of enzymes such as alkaline phosphatases and glucose oxidase. The devices are fragmented on the basis of technology and are used for a wide range of applications such as oncology, endocrinology, autoimmunity, toxicology, haematology, neonatal screening, and others.
The most significant key factors driving the growth of the Global Enzyme Immunoassay (EIA) Reagents and Devices Market are rising prevalence of chronic and infectious diseases coupled with rising geriatric population, rising research and developmental proficiencies by the pharmaceutical companies in order to come up with innovative drugs and healthcare technologies.
The major players covered in the Enzyme Immunoassay (EIA) Reagents And Devices Market report are Thermo Fisher Scientific Inc., BD, QIAGEN, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, Hologic, Inc., Abbott, DSM, DuPont, bioMerieux SA, Promega Corporation., Siemens Healthcare Private Limited, Danaher., Sartorius AG, Sysmex Corporation, Phoenix Pharmaceuticals, DiaSorin S.p.A. and Merck KGaA among other domestic and global players.
Regionally, North America dominates the enzyme immunoassay (EIA) reagents and devices market is expected to continue its dominant trend during the forecast period. This is because of the increased focus to develop novel drugs and biomarkers for various kinds of diseases. Supportive government funding will also propel the growth of enzyme immunoassay (EIA) reagents and devices market in this region. APAC on the other hand will dominate in terms of highest CAGR during the forecast period owing to the increased public and private investment into enzyme immunoassay (EIA) reagents and devices. Rising prevalence of chronic and infectious diseases will further propel the market growth.
Access Complete Report @ https://www.databridgemarketresearch.com/reports/global-enzyme-immunoassay-eia-reagents-and-devices-market .
#Enzyme Immunoassay (EIA) Reagents and Devices#Thermo Fisher#BD#QIAGEN#Agilent#Bio-Rad Lab#Roche#Abbott
1 note
·
View note
Text
Enzyme Immunoassay (EIA) Reagents and Devices Market to Witness Growth rate of 3.9% in Forecast of 2021 to 2028|Key Players Thermo Fisher Scientific Inc., BD, QIAGEN, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc
Enzyme immunoassay (EIA) reagents and devices are used to detect the presence or concentration of an antigen with its application to epidemiological diseases detection. It includes different types of enzymes such as alkaline phosphatases and glucose oxidase. The devices are fragmented on the basis of technology and are used for a wide range of applications such as oncology, endocrinology, autoimmunity, toxicology, haematology, neonatal screening, and others. Rising prevalence of chronic and infectious diseases coupled with rising geriatric population are the major reasons attributable to the growth of enzyme immunoassay (EIA) reagents and devices market. Data Bridge Market Research analyses that the enzyme immunoassay (EIA) reagents and devices market will exhibit a CAGR of around 3.63% for the forecast period of 2021-2028.
Rising prevalence of chronic and infectious diseases is the root cause for the rise in demand for enzyme immunoassay (EIA) reagents and devices. Rising research and developmental proficiencies by the pharmaceutical companies in order to come up with innovative drugs and healthcare technologies are further inducing growth in the demand for enzyme immunoassay (EIA) reagents and devices. Growth and expansion of biotechnological and biopharmaceutical companies is further propelling the market growth. However, lack of awareness and low detection limits for enzyme immunoassay (EIA) reagents and devices in low and middle class economies will challenge the market growth. Inadequate healthcare technological base in these regions will also derail the market growth rate. Unfavourable reimbursement scenario in developing economies will further restrain the scope of growth for this market.
Global Enzyme Immunoassay (EIA) Reagents and Devices Market, By Technology (Enzyme Immunoassays, Fluorescent Immunoassays, Chemiluminescence, Immunoassays, Radioimmunoassay and Others), Product Type (Analysers and Reagents), Application (Oncology, Infectious diseases, Cardiology, Bone and Mineral, Endocrinology, Autoimmunity, Toxicology, Haematology, Neonatal Screening, and Others), End Users (Hospitals, Laboratories, Academics, Pharmaceutical Industries and Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2028 This enzyme immunoassay (EIA) reagents and devices market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on enzyme immunoassay (EIA) reagents and devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Get Sample PDF of Enzyme Immunoassay (EIA) Reagents and Devices Market Report (including COVID19 Impact Analysis) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-enzyme-immunoassay-eia-reagents-and-devices-market
Global Enzyme Immunoassay (EIA) Reagents and Devices Market Scope and Market Size:
The enzyme immunoassay (EIA) reagents and devices market is segmented on the basis of technology, product type, application and end users. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
On the basis of technology, the enzyme immunoassay (EIA) reagents and devices market is segmented into enzyme immunoassays, fluorescent immunoassays, chemiluminescence, immunoassays, radioimmunoassay and others.
On the basis of product type, the enzyme immunoassay (EIA) reagents and devices market is segmented into analysers and reagents.
On the basis of application, the enzyme immunoassay (EIA) reagents and devices market is segmented into oncology, infectious diseases, cardiology, bone and mineral, endocrinology, autoimmunity, toxicology, haematology, neonatal screening, and others.
On the basis of end users, the enzyme immunoassay (EIA) reagents and devices market is segmented into hospitals, laboratories, academics, pharmaceutical industries and others.
Key Market Competitors:
The major players covered in the enzyme immunoassay (EIA) reagents and devices market report are Thermo Fisher Scientific Inc., BD, QIAGEN, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, Hologic, Inc., Abbott, DSM, DuPont, bioMerieux SA, Promega Corporation., Siemens Healthcare Private Limited, Danaher., Sartorius AG, Sysmex Corporation, Phoenix Pharmaceuticals, DiaSorin S.p.A. and Merck KGaA among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
MAJOR TOC OF THE REPORT:
Chapter One: Enzyme Immunoassay (EIA) Reagents and Devices Market Overview
Chapter Two: Manufacturers Profiles
Chapter Three: Enzyme Immunoassay (EIA) Reagents and Devices Market Competition, by Players
Chapter Four: Enzyme Immunoassay (EIA) Reagents and Devices Market Size by Regions
Chapter Five: Enzyme Immunoassay (EIA) Reagents and Devices Market Revenue by Countries
Chapter Six: Enzyme Immunoassay (EIA) Reagents and Devices Market Revenue by Type
Chapter Seven: Enzyme Immunoassay (EIA) Reagents and Devices Market Revenue by Application
Chapter Eight: Enzyme Immunoassay (EIA) Reagents and Devices Market Revenue by Industries
Chapter Nine: Enzyme Immunoassay (EIA) Reagents and Devices Market Revenue by Deployment Model
Chapter Ten: Enzyme Immunoassay (EIA) Reagents and Devices Market Revenue by End User
Get Table of Content on Request @ https://www.databridgemarketresearch.com/toc/?dbmr=global-enzyme-immunoassay-eia-reagents-and-devices-market
Key Report Highlights:
Comprehensive pricing analysis based on different product types and regional segments
Market size data in terms of revenue and sales volume
Deep insights about regulatory and investment scenarios of the global Information Rights Management Market
Analysis of market effect factors and their impact on the forecast and outlook of the global Information Rights Management Market
The detailed assessment of the vendor landscape and leading companies to help understand the level of competition in the global Information Rights Management Market
A roadmap of growth opportunities available in the Global Information Rights Management Market with the identification of key factors
The exhaustive analysis of various trends of the Global Information Rights Management Market to help identify market developments
Key Questions Answered in Report:
What is the key to the Information Rights Management Market?
What will the Information Rights Management Market Demand and what will be Growth?
What are the latest opportunities for Information Rights Management Market in the future?
What are the strengths of the key players?
Access Full Report: https://www.databridgemarketresearch.com/reports/global-enzyme-immunoassay-eia-reagents-and-devices-market
Browse Related Report:
Immunoassay Reagents and Devices Market
North America Immunoassay Reagents and Devices Market
Europe Enzyme Immunoassay (EIA) Reagents and Devices Market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]
1 note
·
View note
Text
Transfection Reagents and Equipment Market Shows Astonishing Growth with Top Influencing Key players | Sigma-Aldrich, Inc.Promega Corporation., QIAGEN.
Transfection Reagents and Equipment Market consist of technology advancements in the transfection technology, rising prevalence of chronic cases, increase in demand of chimeric genes growing alliances between the leading research institutes to trigger drug discovery, increasing R&D spending and research activities by pharmaceutical and biotech companies and rising research activities in cell science.
Asia-Pacific Transfection Reagents And Equipment Market is estimated to grow with the highest CAGR in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
Get Sample Report at :
https://www.databridgemarketresearch.com/request-a-sample/?dbmr=asia-pacific-transfection-reagents-and-equipment-market
Competitive Analysis: Asia-Pacific Transfection Reagents and Equipment Market
Some of the prominent participants operating in this Asia-Pacific Transfection Reagents and Equipment Market are Thermo Fisher Scientific Inc. is expected to dominate the global transfection reagents and equipment market Sigma-Aldrich, Inc (distributor of F. Hoffman La. Roche) followed by Promega Corporation., QIAGEN..
Key Pointers Covered in the Asia-Pacific Transfection Reagents and Equipment Market Trends and Forecast to 2026
Asia-Pacific Transfection Reagents and Equipment Market New Sales Volumes
Asia-Pacific Transfection Reagents and Equipment Market Replacement Sales Volumes
Asia-Pacific Transfection Reagents and Equipment Market Installed Base
Asia-Pacific Transfection Reagents and Equipment Market By Brands
Asia-Pacific Transfection Reagents and Equipment Market Size
Asia-Pacific Transfection Reagents and Equipment Market Procedure Volumes
Asia-Pacific Transfection Reagents and Equipment Market Product Price Analysis
Asia-Pacific Transfection Reagents and Equipment Market Healthcare Outcomes
Asia-Pacific Transfection Reagents and Equipment Market Cost of Care Analysis
Asia-Pacific Transfection Reagents and Equipment Market Regulatory Framework and Changes
Asia-Pacific Transfection Reagents and Equipment Market Prices and Reimbursement Analysis
Asia-Pacific Transfection Reagents and Equipment Market Shares in Different Regions
Recent Developments for Asia-Pacific Transfection Reagents and Equipment Market Competitors
Asia-Pacific Transfection Reagents and Equipment Market Upcoming Applications
Asia-Pacific Transfection Reagents and Equipment Market Innovators Study
Get Detailed TOC:
https://www.databridgemarketresearch.com/toc/?dbmr=asia-pacific-transfection-reagents-and-equipment-market
Scope of the Transfection Reagents and Equipment Market
Asia-Pacific Transfection Reagents and Equipment Market, By Product (Reagents, Equipment), By Method (Physical Method, Biochemical Methods, Viral Methods), By Application (Protein Production, Biomedical Research, Therapeutic Delivery), By End User (Academics & Research Institutes, Pharmaceutical & Biotechnology Companies), By Country (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of APAC) – Industry Trends and Forecast to 2025
Asia-Pacific Transfection Reagents And Equipment Market is estimated to grow with the highest CAGR in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
Prominent factors driving the growth of this market consist of technology advancements in the transfection technology, rising prevalence of chronic cases, increase in demand of chimeric genes growing alliances between the leading research institutes to trigger drug discovery, increasing R&D spending and research activities by pharmaceutical and biotech companies and rising research activities in cell science.
Market Segmentation: Asia-Pacific Transfection Reagents and Equipment Market
The Asia-Pacific transfection reagents and equipment market is segmented based on method categories into three segments; biochemical methods, physical and viral method. In 2018, physical segment is valued to rule with highest market shares, rising at the highest CAGR. Physical segment is dominating the market, as it is the most preferred and highly efficient choice for the transfection. Physical method is further sub segmented into electroporation, nucleofection and others. Other physical method is further divided into genegun, magnetofection, sonoporation and optoinjection. Biochemical method is segmented into lipofection, calcium phosphate, deae-dextran and dendrimers. Viral method is divided into 4 sub segments including adenoviruses, retroviruses, adeno associated viruses and others.
Based on application, the Asia-Pacific transfection reagents and equipment market is segmented into biomedical research, protein production and therapeutic delivery. In 2018, protein production segment is projected to rule with the highest market shares, rising at the highest CAGR. Protein production is dominating the market as protein is an essential requirement for food, healthcare and cosmetics so the protein production is the major application of transfection procedure. Biomedical application is further sub segmented into gene expression studies, cancer research and transgenic models.
The Asia-Pacific transfection reagents and equipment market is segmented based on end user into two notable segments; academics & research institutes and pharmaceutical & biotechnology companies. In 2018, academics & research institutes segment is likely to rule with highest market shares, rising at the highest CAGR. The academics & research institutes are dominating the market as more research is being carried out in research organizations. And research organizations later on licensed out to industries for further development of products.
Reasons to Purchase this Report:
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
Regions/Countries that are expected to witness the fastest growth rates during the forecast period.
The latest developments, market shares, and strategies that are employed by the major market players.
Speak to Author :
https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=asia-pacific-transfection-reagents-and-equipment-market
Key insights in the report:
Complete and distinct analysis of the market drivers and restraints
Key Market players involved in this industry
Detailed analysis of the Market Segmentation
Competitive analysis of the key players involved
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]
Browse Related Report Here:
Enzyme Immunoassay (EIA) Reagents and Devices Market
Newborn Screening Market
#Transfection Reagents and Equipment Market#Transfection Reagents and Equipment Market share#Transfection Reagents and Equipment Market size#Transfection Reagents and Equipment Market trends#Transfection Reagents and Equipment Market news#Transfection Reagents and Equipment Market report#Transfection Reagents and Equipment Market growth#Transfection Reagents and Equipment Market forecast
0 notes
Text
Transfection Reagents and Equipment Market Strategic Insights and key Business Influencing Factors | Major Players – Sigma-Aldrich, Inc.Promega Corporation., QIAGEN..
Transfection Reagents and Equipment Market consist of technology advancements in the transfection technology, rising prevalence of chronic cases, increase in demand of chimeric genes growing alliances between the leading research institutes to trigger drug discovery, increasing R&D spending and research activities by pharmaceutical and biotech companies and rising research activities in cell science.
Asia-Pacific Transfection Reagents And Equipment Market is estimated to grow with the highest CAGR in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
Get Sample Report at :
https://www.databridgemarketresearch.com/request-a-sample/?dbmr=asia-pacific-transfection-reagents-and-equipment-market
Competitive Analysis: Asia-Pacific Transfection Reagents and Equipment Market
Some of the prominent participants operating in this Asia-Pacific Transfection Reagents and Equipment Market are Thermo Fisher Scientific Inc. is expected to dominate the global transfection reagents and equipment market Sigma-Aldrich, Inc (distributor of F. Hoffman La. Roche) followed by Promega Corporation., QIAGEN..
Key Pointers Covered in the Asia-Pacific Transfection Reagents and Equipment Market Trends and Forecast to 2026
Asia-Pacific Transfection Reagents and Equipment Market New Sales Volumes
Asia-Pacific Transfection Reagents and Equipment Market Replacement Sales Volumes
Asia-Pacific Transfection Reagents and Equipment Market Installed Base
Asia-Pacific Transfection Reagents and Equipment Market By Brands
Asia-Pacific Transfection Reagents and Equipment Market Size
Asia-Pacific Transfection Reagents and Equipment Market Procedure Volumes
Asia-Pacific Transfection Reagents and Equipment Market Product Price Analysis
Asia-Pacific Transfection Reagents and Equipment Market Healthcare Outcomes
Asia-Pacific Transfection Reagents and Equipment Market Cost of Care Analysis
Asia-Pacific Transfection Reagents and Equipment Market Regulatory Framework and Changes
Asia-Pacific Transfection Reagents and Equipment Market Prices and Reimbursement Analysis
Asia-Pacific Transfection Reagents and Equipment Market Shares in Different Regions
Recent Developments for Asia-Pacific Transfection Reagents and Equipment Market Competitors
Asia-Pacific Transfection Reagents and Equipment Market Upcoming Applications
Asia-Pacific Transfection Reagents and Equipment Market Innovators Study
Get Detailed TOC:
https://www.databridgemarketresearch.com/toc/?dbmr=asia-pacific-transfection-reagents-and-equipment-market
Scope of the Transfection Reagents and Equipment Market
Asia-Pacific Transfection Reagents and Equipment Market, By Product (Reagents, Equipment), By Method (Physical Method, Biochemical Methods, Viral Methods), By Application (Protein Production, Biomedical Research, Therapeutic Delivery), By End User (Academics & Research Institutes, Pharmaceutical & Biotechnology Companies), By Country (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of APAC) – Industry Trends and Forecast to 2025
Asia-Pacific Transfection Reagents And Equipment Market is estimated to grow with the highest CAGR in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
Prominent factors driving the growth of this market consist of technology advancements in the transfection technology, rising prevalence of chronic cases, increase in demand of chimeric genes growing alliances between the leading research institutes to trigger drug discovery, increasing R&D spending and research activities by pharmaceutical and biotech companies and rising research activities in cell science.
Market Segmentation: Asia-Pacific Transfection Reagents and Equipment Market
The Asia-Pacific transfection reagents and equipment market is segmented based on method categories into three segments; biochemical methods, physical and viral method. In 2018, physical segment is valued to rule with highest market shares, rising at the highest CAGR. Physical segment is dominating the market, as it is the most preferred and highly efficient choice for the transfection. Physical method is further sub segmented into electroporation, nucleofection and others. Other physical method is further divided into genegun, magnetofection, sonoporation and optoinjection. Biochemical method is segmented into lipofection, calcium phosphate, deae-dextran and dendrimers. Viral method is divided into 4 sub segments including adenoviruses, retroviruses, adeno associated viruses and others.
Based on application, the Asia-Pacific transfection reagents and equipment market is segmented into biomedical research, protein production and therapeutic delivery. In 2018, protein production segment is projected to rule with the highest market shares, rising at the highest CAGR. Protein production is dominating the market as protein is an essential requirement for food, healthcare and cosmetics so the protein production is the major application of transfection procedure. Biomedical application is further sub segmented into gene expression studies, cancer research and transgenic models.
The Asia-Pacific transfection reagents and equipment market is segmented based on end user into two notable segments; academics & research institutes and pharmaceutical & biotechnology companies. In 2018, academics & research institutes segment is likely to rule with highest market shares, rising at the highest CAGR. The academics & research institutes are dominating the market as more research is being carried out in research organizations. And research organizations later on licensed out to industries for further development of products.
Reasons to Purchase this Report:
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
Regions/Countries that are expected to witness the fastest growth rates during the forecast period.
The latest developments, market shares, and strategies that are employed by the major market players.
Speak to Author :
https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=asia-pacific-transfection-reagents-and-equipment-market
Key insights in the report:
Complete and distinct analysis of the market drivers and restraints
Key Market players involved in this industry
Detailed analysis of the Market Segmentation
Competitive analysis of the key players involved
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]
Browse Related Report Here:
Enzyme Immunoassay (EIA) Reagents and Devices Market
Newborn Screening Market
#Transfection Reagents and Equipment Market#Transfection Reagents and Equipment Market share#Transfection Reagents and Equipment Market size#Transfection Reagents and Equipment Market trends#Transfection Reagents and Equipment Market news#Transfection Reagents and Equipment Market report#Transfection Reagents and Equipment Market Growth#Transfection Reagents and Equipment Market forecast
0 notes
Text
Orthopedic Implants Market Shows Strong Growth and key Business Influencing Factors | Major Players – Medtronic, Integra LifeSciences Corporation, Zimmer Biomet, Stryker.
Orthopedic Implants Market are the devices that are manufactured to correct the existing problems in the muscle and skeleton in the body. There had been a lot of innovations in the implants which have facilitated the successful implants. These are usually used for treating the back pain and orthopedic implants like bone screws and plates which are used in fixation of fractured bone segments and spinal fusion surgery. With the advent of technology there has been a shift to modern fixation devices from conventional surgical procedures.
Asia-Pacific orthopedic implants market is registering a substantial CAGR in the forecast period of 2019-2026. The rise in the market can be attributed due to the increasing geriatric population and surging incidences of orthopedic diseases are contributing to the market growth.
Get Sample Report at :
https://www.databridgemarketresearch.com/request-a-sample/?dbmr=asia-pacific-orthopedic-implants-market
Competitive Analysis: Asia-Pacific Orthopedic Implants Market
Few of the major market competitors currently working in the Asia-Pacific Orthopedic Implants Market are Baxter, Flexicare Medical Limited, DJO LLC, Medtronic, Integra LifeSciences Corporation, Zimmer Biomet, Stryker, NuVasive Inc., DePuy Synthes, Wright Medical Group N.V., Aesculap Implant Systems, LLC, BioTek Instruments, Inc, CONMED Corporation and Smith & Nephew among others.
Key Pointers Covered in the Asia-Pacific Orthopedic Implants Market Trends and Forecast to 2026
Asia-Pacific Orthopedic Implants Market New Sales Volumes
Asia-Pacific Orthopedic Implants Market Replacement Sales Volumes
Asia-Pacific Orthopedic Implants Market Installed Base
Asia-Pacific Orthopedic Implants Market By Brands
Asia-Pacific Orthopedic Implants Market Size
Asia-Pacific Orthopedic Implants Market Procedure Volumes
Asia-Pacific Orthopedic Implants Market Product Price Analysis
Asia-Pacific Orthopedic Implants Market Healthcare Outcomes
Asia-Pacific Orthopedic Implants Market Cost of Care Analysis
Asia-Pacific Orthopedic Implants Market Regulatory Framework and Changes
Asia-Pacific Orthopedic Implants Market Prices and Reimbursement Analysis
Asia-Pacific Orthopedic Implants Market Shares in Different Regions
Recent Developments for Asia-Pacific Orthopedic Implants Market Competitors
Asia-Pacific Orthopedic Implants Market Upcoming Applications
Asia-Pacific Orthopedic Implants Market Innovators Study
Get Detailed TOC:
https://www.databridgemarketresearch.com/toc/?dbmr=asia-pacific-orthopedic-implants-market
Scope of the Orthopedic Implants Market
Asia-Pacific Orthopedic Implants Market By Product Type (Reconstructive Joint Replacements, Spinal Implants, Dental Implants, Orthobiologics, Trauma & Craniomaxillofacial, Others), Biomaterial (Ceramics Biomaterials, Metallic Biomaterials, Polymeric Biomaterials, Natural Biomaterials), Procedure (Open Surgery, Minimally Invasive Surgery (MIS), Others), Device Type (Internal Fixation Devices, External Fixation Devices), Application (Neck Fracture, Spine Fracture, Hip Replacement, Shoulder Replacement, Others), End User (Hospital, Orthopedic Clinics, Home Cares, Others), Country (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of APAC) - Industry Trends and Forecast to 2026
Asia-Pacific orthopedic implants market is registering a substantial CAGR in the forecast period of 2019-2026. The rise in the market can be attributed due to the increasing geriatric population and surging incidences of orthopedic diseases are contributing to the market growth.
Orthopedic implants are the devices that are manufactured to correct the existing problems in the muscle and skeleton in the body. There had been a lot of innovations in the implants which have facilitated the successful implants. These are usually used for treating the back pain and orthopedic implants like bone screws and plates which are used in fixation of fractured bone segments and spinal fusion surgery. With the advent of technology there has been a shift to modern fixation devices from conventional surgical procedures.
Market Segmentation: Asia-Pacific Orthopedic Implants Market
Few of the major market competitors currently working in the Asia-Pacific orthopedic implants market are Baxter, Flexicare Medical Limited, DJO LLC, Medtronic, Integra LifeSciences Corporation, Zimmer Biomet, Stryker, NuVasive Inc., DePuy Synthes, Wright Medical Group N.V., Aesculap Implant Systems, LLC, BioTek Instruments, Inc, CONMED Corporation and Smith & Nephew among others.
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Reasons to Purchase this Report:
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
Regions/Countries that are expected to witness the fastest growth rates during the forecast period.
The latest developments, market shares, and strategies that are employed by the major market players.
Speak to Author :
https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=asia-pacific-orthopedic-implants-market
Key insights in the report:
Complete and distinct analysis of the market drivers and restraints
Key Market players involved in this industry
Detailed analysis of the Market Segmentation
Competitive analysis of the key players involved
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]
Browse Related Report Here:
Enzyme Immunoassay (EIA) Reagents and Devices Market
Craniomaxilofacial Devices Market
#Orthopedic Implants Market#Orthopedic Implants Market share#Orthopedic Implants Market size#Orthopedic Implants Market trends#Orthopedic Implants Market news#Orthopedic Implants Market report#Orthopedic Implants Market growth#Orthopedic Implants Market forecast
0 notes
Text
Global Immunochemistry Diagnostic Equipment Market Report Trends, Growth and Revenue To 2022
TheBusinessResearchCompany published its Immunochemistry Diagnostic Devices And Equipment Global Market Report 2020 which provides strategists, marketers and senior management with the critical information they need to assess the global immunochemistry diagnostic devices and equipment market. The report covers the immunochemistry diagnostic devices and equipment market’s segments- immunochemistry analyzers, immunochemistry stainers, incubators, microscopes, centrifuges, autoclaves, consumables, endocrinology, oncology, cardiology, therapeutic drug development & monitoring, infectious disease testing, drugs of abuse testing, hospitals and clinics, diagnostic laboratories, research labs and institutes, biopharmaceutical and biotechnology companies, chemiluminescence immunoassay (CLIA) analyzers, immuno fluorescence (IFA) analyzers, enzyme immunoassay (EIA) analyzers, radioimmunoassay (RIA) analyzers, enzyme linked fluorescent assay (ELFA) systems, multiplexed assay systems, automated stainers, semi-automated stainers, antibodies, antigens, enzymes, reagents, stains, & buffers, disposables, and others.
Explore Complete Report https://www.thebusinessresearchcompany.com/report/immunochemistry-diagnostic-devices-and-equipment-global-market-report
Immunochemistry Diagnostic Devices And Equipment Global Market Report 2020 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. It also compares the market’s historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing. The major regions included in the report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Request to get the sample of this report https://www.thebusinessresearchcompany.com/sample.aspx?id=2547&type=smp
Companies in the immunochemistry diagnostic devices and equipment market are increasingly investing in automated immunoassay systems. This is mainly because automation has led to an increase in capabilities of diagnostic devices in testing higher volumes of patient specimens.
Get Discount On This Report https://www.thebusinessresearchcompany.com/sample.aspx?id=2547&type=discount
Chapters from Table of Content:
Chapter 1. Executive Summary
Chapter 2. Immunochemistry Diagnostic Devices And Equipment Market Characteristics
Chapter 3. Immunochemistry Diagnostic Devices And Equipment Market Size And Growth
Chapter 4. Immunochemistry Diagnostic Devices And Equipment Market Segmentation
Chapter 5. Immunochemistry Diagnostic Devices And Equipment Market Regional And Country Analysis
…….
Chapter 27. Immunochemistry Diagnostic Devices And Equipment Market Trends And Strategies
Chapter 28. Immunochemistry Diagnostic Devices And Equipment Market Future Outlook and Potential Analysis
Chapter 29. Appendix
Few Points From List of Tables:
Table 1: Global Historic Market Growth, 2014-2018, $ Billion
Table 2: Global Forecast Market Growth, 2014-2022F, 2025F, 2030F, $ Billion
Table 3: Global Immunochemistry Diagnostic Devices And Equipment Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
………..
Table 70: Siemens Healthcare Diagnostics Financial Performance
Table 71: Diamond Diagnostics Financial Performance
Table 72: Dynex Technologies Financial Performance
Check our blog for more information at http://blog.tbrc.info/
About Us:
The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.
Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: [email protected]
#immunochemistry diagnostic devices#immunochemistry diagnostic equipment#immunochemistry test#immunochemistry diagnostics#immunochemistry assay#immunochemistry analyzer
0 notes
Link
Enzyme immunoassay (EIA) reagents and devices are used to detect the presence and distribution of an analytic in the epidemiological infection identification and vaccine research. It is Clear use of medications, genes, different proteins, cancer markers and heart damage markers. Enzyme Immunoassay (EIA) The demand for reagents and instruments is highly fragmented and is based on new product launches and clinical tests.
#Enzyme Immunoassay (EIA) Reagents and Devices Market#enzyme immunoassay (eia) reagents and devices#Enzyme Immunoassay (EIA) Reagents and Devices Market Trends#Enzyme Immunoassay (EIA) Reagents and Devices Market Industry#Enzyme Immunoassay (EIA) Reagents and Devices Market News#Enzyme Immunoassay (EIA) Reagents and Devices Market Research
0 notes
Link
Enzyme immunoassay (EIA) reagents and devices are used to detect the presence and distribution of an analytic in the epidemiological infection identification and vaccine research. It is Clear use of medications, genes, different proteins, cancer markers and heart damage markers. Enzyme Immunoassay (EIA) The demand for reagents and instruments is highly fragmented and is based on new product launches and clinical tests.
#Enzyme Immunoassay (EIA) Reagents and Devices Market#Enzyme Immunoassay (EIA) Reagents and Devices#Enzyme Immunoassay (EIA) Reagents and Devices Market Trends#Enzyme Immunoassay (EIA) Reagents and Devices Market Industry#Enzyme Immunoassay (EIA) Reagents and Devices Market News#Enzyme Immunoassay (EIA) Reagents and Devices Market Research
0 notes
Text
Global Enzyme Immunoassay (EIA) Reagents and Devices Market Growth, Significant Trends Till 2025
According to Data Bridge Market Research new Market report, “Global Enzyme Immunoassay (EIA) Reagents and Devices Market” By Technology(Enzyme Immunoassays, Fluorescent Immunoassays, Chemiluminescence Immunoassays, Radioimmunoassay, and Others), By product type(Analyzers, Reagents),By Application(Oncology, Infectious Diseases, Cardiology, Bone and Mineral, Endocrinology, Autoimmunity, Toxicology, hematology, neonatal screening, and others),By End-Users(Hospitals, Laboratories, Academics, Pharmaceutical Industries {CRO’s, Biotech}, Others), By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends and Forecast is projected to reach USD 11.28 billion by 2025, at a CAGR of 4.2% during the forecast period of 2018 to 2025.
Get free sample @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-enzyme-immunoassay-eia-reagents-and-devices-market
Global Enzyme Immunoassay Reagents and Devices Market
Enzyme Immunoassay (EIA) Reagents and Devices are used to detect the presence of antigen or concentration of an analyteswith its applicability to epidemiological diseases detection and vaccine trials. The basic use is for measurement of drugs, hormones, specific proteins, tumor markers, and markers of cardiac injury. Enzyme immunoassay (EIA) Reagents associated Devices are accustomed discover the presence of substance or concentration of an enzyme with its pertinence to epidemiologic diseases detection and immunizing agent trials.
Immunoassays generally fall into two categories. First, antibody-antigen precipitation tests, such as radial immunodiffusion, hemagglutination, and coated latex particle agglutination. Second, labeled-reagent tests, such as radioimmunoassay, and enzyme-linked immunoassay.
Enzyme immunoassays (EIAs), also known as enzyme-linked immunosorbent assays (ELISAs), combine antibody binding with enzymatic detection to quantify molecules of interest. EIAs are easy to perform, require little specialized equipment, and both the experienced lab technician and the research lab novice can learn EIA skills quickly. EIA is often regarded as the test used to detect HIV.
The enzyme-linked immunosorbent assay (ELISA) is a diagnostic test that uses antibodies and color change to identify a substance. The ELISA has been used as a diagnostic tool in medicine and plant pathology, as well as a quality-control check in various industries. Antigens from the sample are attached to a surface. Then, a further specific antibody is applied over the surface so it can bind to the antigen. This antibody is linked to an enzyme, and, in the final step, a substance containing the enzyme’s substrate is added. The subsequent reaction produces a detectable signal, most commonly a color change in the substrate.
Rapid diagnostic tests allowing for the qualitative and quantitative determination of a number of differing analytes hold great potential for acceptance by both laboratory and field personnel. In the clinical laboratory, rapid, sensitive, specific and accurate tests based upon the presence or absence of analyte in biological specimens provide possibilities for the early detection, confirmed diagnosis, and prompt treatment for many pathological conditions. In the field, the potential use of such tests may be extended to determine the presence or absence of differing analytes in air, food, water or soil.
The advantage and acceptance of the diagnostic devices and kits to perform such rapid analysis depends on a number of factors such as sensitivity, specificity, cost per test, ease of use, and timeliness of test results. Ideally, to be accepted by the user, such a device or kit should be simple to perform with rapid, easy to interpret and virtually foolproof results. In addition, such a device should be easily transportable, capable of providing the results of the test “on site”, and disposable after use.
Enzyme immunoassay has wide range of application in clinical laboratories and one of the largest application is related to the detections of viruses. For example, the screening and diagnosis of hepatitis virus is routinely used in the lab. These include the detection of HBsAg and HBeAg by direct ELISA, anti-HBc antibody and anti-HBe antibody by competitive ELISA and anti-HBs antibody by indirect ELISA. What is more, ELISA can detect HCV antibodies in serum samples as screening tests and the positive samples are conformed by molecular HCV RNA.
The Advantageous effect of using an enzyme immunoassay in clinical hematology is that it got the ability to identify alloantibodies in patients who frequently receive platelet transfusions for therapeutic purposes. It has been demonstrated that ELISA is more sensitive to the detection of alloantibodies than other immunoassays, such as Lymphocytotoxic Test (LCT) and the Platelet Immunofluorescence Test (PIFT), and it is performed in a short period of time. Furthermore, enzyme immunoassays are able to detect anti-platelet antibodies, Platelet Associated IgG (PAIgG) , HLA and circulating antibodies in patients with Idiopathic Thrombocytopenic Purpura (ITP).
There are various evidence which suggest that a ubiquitous herpes virus, in particular Epstein-Barr virus (EBV), is implicated in many types of lymphoma such as Hodgkin’s disease and Burkitt’s lymphoma, so the early detection of EBV antigen specific T cells is essential and therefore ELISPOT assay can be used to analyse T cell responses.
Another of its feature is related to acquire von Willebrand syndrome, which is caused by autoantibodies against von Willebrand factor (vWF). This plays an essential role in hemostasis and is characterized by prolonged bleeding due to the defect in vWF activity. Detection of anti-vWF antibody can be performed by ELISA (Mohri 2003), mention that competitive ELISA is a useful technique in the detection of anti-vWFA antibodies in a clinical samples.
Despite the benefits of ELISA in the detection of HLA class I specific antibodies, it is less sensitive than flow cytometry, so before platelet transplantation, flow cytometry must be used. Although chemiluminescence immunoassay has great sensitivity in detecting HBsAg in blood donor samples, it has less sensitivity than the polymerase chain reaction (PCR), so to increase the safety of blood from HIV-1 , HCV, and HBV, the nucleic acid amplification technique (NAT) has been applied for the screening of blood donor samples.
Inquire before buying @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-enzyme-immunoassay-eia-reagents-and-devices-market
Market Segmentation: Global Enzyme Immunoassay Reagents and Devices Market
The global market for Enzyme immunoassay reagents and device by the following sub-categories is presented
· By Application
o Oncology
o Infectious diseases
o Cardiology
o Bone and Mineral
o Endocrinology
o Autoimmunity
o Toxicology
o Hematology
o Neonatal Screening
o Others
· By Technology
o Enzyme immunoassays
o Fluorescent immunoassays
o Chemiluminescence immunoassays
o Radioimmunoassay and others
· By product type
o Analyzers
o Reagents
· By Geography
o North America
o South America
o Europe
o Asia-Pacific
o Middle East and Africa
· By End-Users
o Hospitals
o Laboratories
o Academics
o Pharmaceutical Industries
o Others
FACTORS DRIVING GROWTH IN THE GLOBAL ENZYME IMMUNOASSAY REAGENTS AND DEVICES MARKET:
Rising Usage of Novel Biomarkers and Innovative Technologies:
Biomarkers represent powerful tools for diseases detection, determining the efficacy and safety of novel therapeutic agents and monitoring disease recurrence.
Identification of key biomarkers at early stages of diseases that can be easily obtained by the least invasive methods is critical for early diagnosis of cancer diagnosis. Human body fluids, such as blood, present a promising resource for biomarkers. Routine detection of biomarkers is critical to bring substantial advances in molecular medicine and transform many areas of medicine from clinical trials to diagnosis and treatment of complex diseases.
Survival of cancer patients depends heavily on early detection and therefore, developing new technologies allows for a quick, sensitive and cost effective method is critical for cancer research . Early detection is an important factor in determining the survival of patients with hepatocellular carcinoma (HCC). However, early diagnosis of cancer is still difficult to achieve due to the lack of specific symptoms in early stages of the disease where detection of biomarkers is still unattainable due to low detection levels.
Recent advances in detection technologies hold promises to identify novel biomarkers reliably and accurately to predict outcomes during cancer treatment and management. Additionally, the new technologies provide higher analytical capabilities, employing automated liquid handling systems for greater sensitivity, more robust and higher throughput sample analysis.
Rising Incidence of Chronic and Infectious Diseases:
The last half century has seen a steady increase in the incidence and prevalence of chronic inflammatory diseases with further increases expected. This may be due to number of factors such as:
· Misuse of antibiotics especially Beta-lactam antibiotics
· Vitamin supplementation including folic acid but especially vitamin D
· Presence of environmental factors which suppress immunity
· Novel vectors for sharing pathogens including blood donation
· Widespread adoption of compulsory mass vaccinations
Chronic diseases are the largest cause of death in the world. The leading chronic diseases—cardiovascular disease, cancer, chronic respiratory disease, and diabetes—caused 29 million deaths worldwide. Annual mortality due to chronic disease is expected to increase in real numbers as well as relative to deaths from injuries and diseases traditionally understood to be infectious such as polio, rubella, tuberculosis, etc.
The 2014 Ebola outbreak in West Africa dramatically raised awareness of the global burden of infectious disease and raised questions about the preparedness of public health systems. In February 2016, the public scrambled to understand the implications of the Zika virus after the World Health Organization designated it as an international public health emergency because of the suspected relationship between Zika and a rise in cases of a rare congenital condition called microcephaly in Brazil. Although non-communicable diseases are the leading cause of morbidity and mortality in most developed nations, infectious disease remains a major public health concern in the United States and around the world.
A 2014 report by the U.S. Centers for Disease Control and Prevention found that salmonella was responsible for more cases of illness, hospitalizations and deaths than any other food-borne pathogen. A 2012 study published in Lancet Infectious Diseases reviews non-infectious disease risks from mass-gatherings. A 2011 report by the World Health Organization reviewed the causes of death globally, and identified ways by which to measure progress in infectious disease, among other types and indicators of morbidity and mortality.
Some of the major players operating in Enzyme Immunoassay (EIA) Reagents and devicesmarket are
· Novozymes,
· DSM,
· DuPont ,
· Siemens,
· Roche Diagnostics,
· Abbott Laboratories,
· Danaher Corporation,
· Ortho Clinical Diagnostics,
· BioMerieux,
· Randox Laboratories Ltd,
· Biohit Oyj,
· Meril Life Sciences Pvt. Ltd,
· Tosoh Corporation,
· Inova Diagnostics,
· IASON GmbH,
· Radiometer Medical ApS ,
· Lifotronic Technology Co., Ltd,
· PerkinElmer Inc,
· Molecular Devices, LLC ,
· bioMérieux SA,
· HYCOR Biomedical.
Access Full Report: http://databridgemarketresearch.com/reports/global-hla-typing-transplant-diagnostics-services-market/
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]
#Global Enzyme Immunoassay (EIA) Reagents and Devices Market report#Global Enzyme Immunoassay (EIA) Reagents and Devices Market trend#Global Enzyme Immunoassay (EIA) Reagents and Devices Market Segments#Global Enzyme Immunoassay (EIA) Reagents and Devices Market growth
0 notes
Text
Human T-Lymphotropic Virus (HTLV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 market impact) published on
https://www.sandlerresearch.org/human-t-lymphotropic-virus-htlv-tests-in-vitro-diagnostics-global-market-analysis-and-forecast-model-covid-19-market-impact.html
Human T-Lymphotropic Virus (HTLV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 market impact)
Human T-Lymphotropic Virus (HTLV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model (COVID-19 market impact)
Summary
Human T-Lymphotropic Virus (HTLV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area.
The model discusses in detail the impact of COVID-19 on Human T-Lymphotropic Virus (HTLV) Tests market for the year 2020 and beyond. Human T-Lymphotropic Virus (HTLV) is a retrovirus that infects T Lymphocyte cells. There are four strains of Human T-Lymphotropic Virus (HTLV), out of these Human T-Lymphotropic Virus (HTLV)-I and Human T-Lymphotropic Virus (HTLV)-II are the most prevalent. Human T-Lymphotropic Virus (HTLV) testing is often performed in patients with lymphomas or T cell disorders as part of ATLL diagnosis. Human T-Lymphotropic Virus (HTLV) tests are performed in Artificial Insemination, and blood donors.
Medical devices covered in this market model include EIA and NAAT testing reagents as well as antigens, clinical grade antibodies, controls, and calibration materials. EIA/ELISA test includes both Chemiluminescence Immunoassay (CLIA) and Enzyme-linked Immunosorbent Assay (ELISA) devices. This method tests for the presence of Human T-Lymphotropic Virus (HTLV)-I and Human T-Lymphotropic Virus (HTLV)-II antibodies.
Each of the covered 39 country’s color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are –
Currently marketed Human T-Lymphotropic Virus (HTLV) Tests and evolving competitive landscape – – Insightful review of the key industry trends. – Annualized total Human T-Lymphotropic Virus (HTLV) Tests market revenue by segment and market outlooks from 2015-2030. – Granular data on total procedures, units, average selling prices and market values by segment.
Global, Regional and Country level market specific insights – – Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market. – SWOT analysis for Human T-Lymphotropic Virus (HTLV) Tests market. – Competitive dynamics insights and trends provided for Human T-Lymphotropic Virus (HTLV) Tests market.
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape. – Country specific overview of the healthcare system. – Country specific reimbursement policies. – Country specific medtech regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Abbott Laboratories , F. Hoffmann-La Roche Ltd , Miraca Holdings Inc , MP Biomedicals LLC , DiaSorin SpA and Others
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.
Scope
This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for – – CMO executives who must have deep understanding of the Human T-Lymphotropic Virus (HTLV) Tests market place to make strategic planning and investment decisions. – Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management. – Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.
Reasons to Buy
The model will enable you to – – Understand the impact of COVID-19 on Human T-Lymphotropic Virus (HTLV) Tests market. – Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline. – Develop business strategies by understanding the trends shaping and driving Human T-Lymphotropic Virus (HTLV) Tests. – Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Human T-Lymphotropic Virus (HTLV) Tests market in the future. – Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the company share of market leaders. – Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. – Track device sales in the global and country-specific Human T-Lymphotropic Virus (HTLV) Tests market from 2015-2030. – Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
0 notes
Link
Rising prevalence of chronic and infectious diseases coupled with rising geriatric population are the major reasons attributable to the growth of enzyme immunoassay (EIA) reagents and devices market. Data Bridge Market Research analyses that the enzyme immunoassay (EIA) reagents and devices market will exhibit a CAGR of around 3.63% for the forecast period of 2021-2028.
0 notes
Text
Transfection Reagents and Equipment Market Strategic Insights and key Business Influencing Factors | Major Players – Sigma-Aldrich, Inc (distributor of F. Hoffman La. Roche),Promega Corporation., QIAGEN..
Transfection Reagents and Equipment Market consist of technology advancements in the transfection technology, rising prevalence of chronic cases, increase in demand of chimeric genes growing alliances between the leading research institutes to trigger drug discovery, increasing R&D spending and research activities by pharmaceutical and biotech companies and rising research activities in cell science.
Asia-Pacific is estimated to grow with the highest CAGR in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
Get Sample Report at :
https://www.databridgemarketresearch.com/request-a-sample/?dbmr=asia-pacific-transfection-reagents-and-equipment-market
Competitive Analysis: Asia-Pacific Transfection Reagents and Equipment Market
Some of the prominent participants operating in this market are Thermo Fisher Scientific Inc. is expected to dominate the global transfection reagents and equipment market Sigma-Aldrich, Inc (distributor of F. Hoffman La. Roche) followed by Promega Corporation., QIAGEN..
Key Pointers Covered in the Asia-Pacific Transfection Reagents and Equipment Market Trends and Forecast to 2026
Asia-Pacific Transfection Reagents and Equipment Market New Sales Volumes
Asia-Pacific Transfection Reagents and Equipment Market Replacement Sales Volumes
Asia-Pacific Transfection Reagents and Equipment Market Installed Base
Asia-Pacific Transfection Reagents and Equipment Market By Brands
Asia-Pacific Transfection Reagents and Equipment Market Size
Asia-Pacific Transfection Reagents and Equipment Market Procedure Volumes
Asia-Pacific Transfection Reagents and Equipment Market Product Price Analysis
Asia-Pacific Transfection Reagents and Equipment Market Healthcare Outcomes
Asia-Pacific Transfection Reagents and Equipment Market Cost of Care Analysis
Asia-Pacific Transfection Reagents and Equipment Market Regulatory Framework and Changes
Asia-Pacific Transfection Reagents and Equipment Market Prices and Reimbursement Analysis
Asia-Pacific Transfection Reagents and Equipment Market Shares in Different Regions
Recent Developments for Asia-Pacific Transfection Reagents and Equipment Market Competitors
Asia-Pacific Transfection Reagents and Equipment Market Upcoming Applications
Asia-Pacific Transfection Reagents and Equipment Market Innovators Study
Get Detailed TOC:
https://www.databridgemarketresearch.com/toc/?dbmr=asia-pacific-transfection-reagents-and-equipment-market
Scope of the Transfection Reagents and Equipment Market
Asia-Pacific Transfection Reagents and Equipment Market, By Product (Reagents, Equipment), By Method (Physical Method, Biochemical Methods, Viral Methods), By Application (Protein Production, Biomedical Research, Therapeutic Delivery), By End User (Academics & Research Institutes, Pharmaceutical & Biotechnology Companies), By Country (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of APAC) – Industry Trends and Forecast to 2025
Asia-Pacific Transfection Reagents And Equipment Market is estimated to grow with the highest CAGR in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
Prominent factors driving the growth of this market consist of technology advancements in the transfection technology, rising prevalence of chronic cases, increase in demand of chimeric genes growing alliances between the leading research institutes to trigger drug discovery, increasing R&D spending and research activities by pharmaceutical and biotech companies and rising research activities in cell science.
Market Segmentation: Asia-Pacific Transfection Reagents and Equipment Market
Global Transfection Reagents and Equipment Market is segmented based on products into two segments; reagents and equipment. In 2018, reagents segment is estimated to rule with highest market shares, rising at a specified CAGR. However, equipment is growing at the highest CAGR of 9.6% in the forecast period of 2018 to 2025.
The Asia-Pacific transfection reagents and equipment market is segmented based on method categories into three segments; biochemical methods, physical and viral method. In 2018, physical segment is valued to rule with highest market shares, rising at the highest CAGR. Physical segment is dominating the market, as it is the most preferred and highly efficient choice for the transfection. Physical method is further sub segmented into electroporation, nucleofection and others. Other physical method is further divided into genegun, magnetofection, sonoporation and optoinjection. Biochemical method is segmented into lipofection, calcium phosphate, deae-dextran and dendrimers. Viral method is divided into 4 sub segments including adenoviruses, retroviruses, adeno associated viruses and others.
Based on application, the Asia-Pacific transfection reagents and equipment market is segmented into biomedical research, protein production and therapeutic delivery. In 2018, protein production segment is projected to rule with the highest market shares, rising at the highest CAGR. Protein production is dominating the market as protein is an essential requirement for food, healthcare and cosmetics so the protein production is the major application of transfection procedure. Biomedical application is further sub segmented into gene expression studies, cancer research and transgenic models.
The Asia-Pacific transfection reagents and equipment market is segmented based on end user into two notable segments; academics & research institutes and pharmaceutical & biotechnology companies. In 2018, academics & research institutes segment is likely to rule with highest market shares, rising at the highest CAGR. The academics & research institutes are dominating the market as more research is being carried out in research organizations. And research organizations later on licensed out to industries for further development of products.
Reasons to Purchase this Report:
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
Regions/Countries that are expected to witness the fastest growth rates during the forecast period.
The latest developments, market shares, and strategies that are employed by the major market players.
Speak to Author :
https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=asia-pacific-transfection-reagents-and-equipment-market
Key insights in the report:
Complete and distinct analysis of the market drivers and restraints
Key Market players involved in this industry
Detailed analysis of the Market Segmentation
Competitive analysis of the key players involved
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]
Transfection Reagents and Equipment Market Similar Report Here:
Enzyme Immunoassay (EIA) Reagents and Devices Market
Newborn Screening Market
#Transfection Reagents and Equipment Market#Transfection Reagents and Equipment Market share#Transfection Reagents and Equipment Market size#Transfection Reagents and Equipment Market trends#Transfection Reagents and Equipment Market news#Transfection Reagents and Equipment Market growth#Transfection Reagents and Equipment Market market#Transfection Reagents and Equipment Market forecast#Transfection Reagents and Equipment Market report#Transfection Reagents and Equipment Market research
0 notes
Text
Orthopedic Implants Market Will Accelerate Rapidly with Top Influencing Key players| Medtronic, Integra LifeSciences Corporation, Zimmer Biomet, Stryker.
Orthopedic Implants Market are the devices that are manufactured to correct the existing problems in the muscle and skeleton in the body. There had been a lot of innovations in the implants which have facilitated the successful implants. These are usually used for treating the back pain and orthopedic implants like bone screws and plates which are used in fixation of fractured bone segments and spinal fusion surgery. With the advent of technology there has been a shift to modern fixation devices from conventional surgical procedures.
Asia-Pacific orthopedic implants market is registering a substantial CAGR in the forecast period of 2019-2026. The rise in the market can be attributed due to the increasing geriatric population and surging incidences of orthopedic diseases are contributing to the market growth.
Get Sample Report at :
https://www.databridgemarketresearch.com/request-a-sample/?dbmr=asia-pacific-orthopedic-implants-market
Competitive Analysis: Asia-Pacific Orthopedic Implants Market
Few of the major market competitors currently working in the Asia-Pacific Orthopedic Implants Market are Baxter, Flexicare Medical Limited, DJO LLC, Medtronic, Integra LifeSciences Corporation, Zimmer Biomet, Stryker, NuVasive Inc., DePuy Synthes, Wright Medical Group N.V., Aesculap Implant Systems, LLC, BioTek Instruments, Inc, CONMED Corporation and Smith & Nephew among others.
Key Pointers Covered in the Asia-Pacific Orthopedic Implants Market Trends and Forecast to 2026
Asia-Pacific Orthopedic Implants Market New Sales Volumes
Asia-Pacific Orthopedic Implants Market Replacement Sales Volumes
Asia-Pacific Orthopedic Implants Market Installed Base
Asia-Pacific Orthopedic Implants Market By Brands
Asia-Pacific Orthopedic Implants Market Size
Asia-Pacific Orthopedic Implants Market Procedure Volumes
Asia-Pacific Orthopedic Implants Market Product Price Analysis
Asia-Pacific Orthopedic Implants Market Healthcare Outcomes
Asia-Pacific Orthopedic Implants Market Cost of Care Analysis
Asia-Pacific Orthopedic Implants Market Regulatory Framework and Changes
Asia-Pacific Orthopedic Implants Market Prices and Reimbursement Analysis
Asia-Pacific Orthopedic Implants Market Shares in Different Regions
Recent Developments for Asia-Pacific Orthopedic Implants Market Competitors
Asia-Pacific Orthopedic Implants Market Upcoming Applications
Asia-Pacific Orthopedic Implants Market Innovators Study
Get Detailed TOC:
https://www.databridgemarketresearch.com/toc/?dbmr=asia-pacific-orthopedic-implants-market
Scope of the Orthopedic Implants Market
Asia-Pacific Orthopedic Implants Market By Product Type (Reconstructive Joint Replacements, Spinal Implants, Dental Implants, Orthobiologics, Trauma & Craniomaxillofacial, Others), Biomaterial (Ceramics Biomaterials, Metallic Biomaterials, Polymeric Biomaterials, Natural Biomaterials), Procedure (Open Surgery, Minimally Invasive Surgery (MIS), Others), Device Type (Internal Fixation Devices, External Fixation Devices), Application (Neck Fracture, Spine Fracture, Hip Replacement, Shoulder Replacement, Others), End User (Hospital, Orthopedic Clinics, Home Cares, Others), Country (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of APAC) - Industry Trends and Forecast to 2026
Asia-Pacific orthopedic implants market is registering a substantial CAGR in the forecast period of 2019-2026. The rise in the market can be attributed due to the increasing geriatric population and surging incidences of orthopedic diseases are contributing to the market growth.
Orthopedic implants are the devices that are manufactured to correct the existing problems in the muscle and skeleton in the body. There had been a lot of innovations in the implants which have facilitated the successful implants. These are usually used for treating the back pain and orthopedic implants like bone screws and plates which are used in fixation of fractured bone segments and spinal fusion surgery. With the advent of technology there has been a shift to modern fixation devices from conventional surgical procedures.
Market Segmentation: Asia-Pacific Orthopedic Implants Market
Few of the major market competitors currently working in the Asia-Pacific orthopedic implants market are Baxter, Flexicare Medical Limited, DJO LLC, Medtronic, Integra LifeSciences Corporation, Zimmer Biomet, Stryker, NuVasive Inc., DePuy Synthes, Wright Medical Group N.V., Aesculap Implant Systems, LLC, BioTek Instruments, Inc, CONMED Corporation and Smith & Nephew among others.
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Reasons to Purchase this Report:
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
Regions/Countries that are expected to witness the fastest growth rates during the forecast period.
The latest developments, market shares, and strategies that are employed by the major market players.
Speak to Author :
https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=asia-pacific-orthopedic-implants-market
Key insights in the report:
Complete and distinct analysis of the market drivers and restraints
Key Market players involved in this industry
Detailed analysis of the Market Segmentation
Competitive analysis of the key players involved
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]
Browse Related Report Here:
Enzyme Immunoassay (EIA) Reagents and Devices Market
Craniomaxilofacial Devices Market
#Orthopedic Implants Market#Orthopedic Implants Market share#Orthopedic Implants Market size#Orthopedic Implants Market trends#Orthopedic Implants Market news#Orthopedic Implants Market report#Orthopedic Implants Market growth
0 notes
Text
Blood Screening Market Strategic Insights and key Business Influencing Factors | Major Players – Thermo Fisher Scientific Inc. , BioMérieux SA , Beckman Coulter, Inc. , Abbott , F. Hoffmann-La Roche Ltd.
Blood Screening Market Screening process can also be called as the first line of defense in health care field providing a safe blood supply and helping in minimizing the problems associated with transfusion-transmitted infection. Government associations from every country should establish blood donor programs to provide information and education about blood donations. Various techniques are available in the market to perform assays for detection of the problems related to health is Immunoassays (IAs) and Nucleic Acid Amplification Technology (NAT) assays. Immunoassay is categorized into enzyme immunoassays (EIAs), chemiluminescent immunoassays (CLIAs), haemagglutination (HA)/particle agglutination (PA) assays andsimple single-use assays (rapid tests).
Asia Pacific blood screening market is expected to register a healthy CAGR of 10.5% in the forecast period of 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
Get Sample Report at :
https://www.databridgemarketresearch.com/request-a-sample/?dbmr=asia-pacific-blood-screening-market
Competitive Analysis: Asia-Pacific Blood Screening Market
Some of the prominent participants operating in this market are Enzo Biochem Inc., Meridian Bioscience, Inc, BD , Bio-Rad Laboratories, Inc. , Thermo Fisher Scientific Inc. , BioMérieux SA , Beckman Coulter, Inc. , Abbott , F. Hoffmann-La Roche Ltd (Switzerland), Cepheid , GRIFOLS INTERNATIONAL, S.A. , Siemens AG , Ortho Clinical Diagnostics , Immucor, Inc., Hologic Inc. , among others.
High Temperature Elastomer Market Size, Status and Forecast 2026
Market Overview
Manufacturers Profiles
Blood Screening Sales, Revenue, Market Share and Competition by Manufacturer
Blood Screening Market Analysis by Regions
North America Blood Screening by Countries
Europe Blood Screening by Countries
Asia-Pacific Blood Screening by Countries
South America Blood Screening by Countries
Middle East and Africa Blood Screening by Countries
Blood Screening Market Segment by Type
Blood Screening Market Segment by Application
Blood Screening Market Forecast
Sales Channel, Distributors, Traders and Dealers
Research Findings and Conclusion
Appendixes
Get Detailed TOC:
https://www.databridgemarketresearch.com/toc/?dbmr=asia-pacific-blood-screening-market
Scope of the Blood Screening Market
Asia Pacific Blood Screening Market, By Products & Services (Reagents & Kits, Instruments, Software & Services), Technology (Enzyme-Linked Immunosorbent Assay, Rapid Tests, Next-Generation Sequencing, Nucleic Acid Test, Western Blot Assay, Others), Disease Type (Oncology, Diabetes Mellitus, Cold & Flu, Cholesterol, Infectious Diseases, Respiratory Diseases, HIV/AIDS, Others), End User (Diagnostic Centers, Blood Bank, Hospitals, Clinics, Ambulatory Surgical Centers), Geography (North America, Europe, Asia-Pacific, South America, Middle East & Africa)- Industry Trends and Forecast to 2025
Screening process can also be called as the first line of defense in health care field providing a safe blood supply and helping in minimizing the problems associated with transfusion-transmitted infection. Government associations from every country should establish blood donor programs to provide information and education about blood donations. Various techniques are available in the market to perform assays for detection of the problems related to health is Immunoassays (IAs) and Nucleic Acid Amplification Technology (NAT) assays. Immunoassay is categorized into enzyme immunoassays (EIAs), chemiluminescent immunoassays (CLIAs), haemagglutination (HA)/particle agglutination (PA) assays andsimple single-use assays (rapid tests).
Asia Pacific blood screening market is expected to register a healthy CAGR of 10.5% in the forecast period of 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
Market Segmentation: Asia-Pacific Blood Screening Market
Global Blood Screening Market is segmented into reagents & kits, instruments and software & services. Reagents & kits are further sub segmented into NAT reagents & kits, ELISA reagents & kits and others reagents. NAT reagents is further sub segmented into enzymes and polymerases, standards and controls, probes and primers, buffers, nucleotides and solutions also labeling and detection reagents. ELISA reagents & kits are further sub segmented into immunosorbents, controls, conjugates (antigen or antibody-conjugated enzyme), substrates (of enzymes) and sample diluents and wash solutions. Instruments segment are further segmented into instruments, product type and instruments, purchase type. In 2017, reagents & kits segment is expected to dominate the global blood screening market with 49.1% market share and is expected to grow at the CAGR of 9.4% in the forecast period 2018 to 2025. However, instruments segment is expected to grow at the highest CAGR of 10.2% in the forecast period,
In January 2017, F. Hoffmann-La Roche Ltd (Switzerland) launched haematology testing solution. This solution is called the cobas m 511 integrated haematology analyser. This launch marked the entry for Roche Diagnostics in the haematology market.
On the basis of disease type, the market is segmented into respiratory diseases, diabetes mellitus, oncology, cholesterol, HIV/AIDS, cold & flu, infectious diseases and others. In 2017, oncology segment is expected to dominate the global blood screening market with 24.9% market sharegrowing at the highest CAGR of 10.3% in the forecast period 2018 to 2025.
In June 2018, Thermo Fisher Scientific (U.S.) launched Oncomine TCR Beta-SR Assay. It is a new next-generation sequencing (NGS) solution in the field of immuno-oncology research. This helped company to expand their business by enhancing their product portfolio.
On the basis of end user the market is segmented into hospitals, clinics, diagnostic centers, blood bank and ambulatory surgical cenetrs. In 2017, diagnostic centers segment is expected to dominate the global blood screening market with 28.8% market share, growing at the highest CAGR of 10.4%in the forecast period 2018 to 2025.
In September 2016, Siemens Healthineers (Germany) acquired Conworx Technology GmbH (Germany) for point-of-care device interfaces and data management solutions. The company’s products and solutions designed helped in increasing efficiency and to reduce costs.
Reasons to Purchase this Report:
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
Regions/Countries that are expected to witness the fastest growth rates during the forecast period.
The latest developments, market shares, and strategies that are employed by the major market players.
Speak to Author :
https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=asia-pacific-blood-screening-market
Key insights in the report:
Complete and distinct analysis of the market drivers and restraints
Key Market players involved in this industry
Detailed analysis of the Market Segmentation
Competitive analysis of the key players involved
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]
#Blood Screening Market#Blood Screening Market share#Blood Screening Market size#Blood Screening Market trends#Blood Screening Market report#Blood Screening Market news#Blood Screening Market research#Blood Screening Market overview
0 notes